Celltrion Healthcare

Yuflyma

Yuflyma

• Product Name : Yuflyma®
• INN : adalimumab
• Indications : Rheumatoid arthritis, Axial spondyloarthritis, Psoriasis, Psoriatic arthritis, Crohn’s disease, Hidradenitis suppurativa, Ulcerative colitis, Uveitis, Paediatric plaque psoriasis, paediatric Crohn’s disease, paediatric ulcerative colitis, paediatric uveitis, juvenile idiopathic arthritis
• Protein Type : Monoclonal antibody (mAb)
• Mechanism of Action : Specifically targets and blocks TNF-alpha which contributes to the inflammation.
• Drug Approval Status : EU (2021-02-11)